Switch theme
Sign up to access all valuation multiples
Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which includes herbal products, daily health products, raw medicine, drug classics and among others.
1993
3.5K+
LTM Revenue $5.6B
LTM EBITDA $767M
$12.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Yunnan Baiyao Group has a last 12-month revenue of $5.6B and a last 12-month EBITDA of $767M.
In the most recent fiscal year, Yunnan Baiyao Group achieved revenue of $5.5B and an EBITDA of $835M.
Yunnan Baiyao Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Yunnan Baiyao Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $5.4B | $5.5B | XXX | XXX | XXX |
| Gross Profit | $1.3B | $1.4B | XXX | XXX | XXX |
| Gross Margin | 25% | 26% | XXX | XXX | XXX |
| EBITDA | $717M | $835M | XXX | XXX | XXX |
| EBITDA Margin | 13% | 15% | XXX | XXX | XXX |
| Net Profit | $413M | $564M | XXX | XXX | XXX |
| Net Margin | 8% | 10% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Yunnan Baiyao Group's stock price is CNY 57 (or $8).
Yunnan Baiyao Group has current market cap of CNY 101B (or $13.9B), and EV of CNY 88.3B (or $12.2B).
See Yunnan Baiyao Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.2B | $13.9B | XXX | XXX | XXX | XXX | $0.38 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Yunnan Baiyao Group has market cap of $13.9B and EV of $12.2B.
Yunnan Baiyao Group's trades at 2.2x LTM EV/Revenue multiple, and 15.9x LTM EBITDA.
Analysts estimate Yunnan Baiyao Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Yunnan Baiyao Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $12.2B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 14.6x | XXX | XXX | XXX |
| P/E | 21.3x | XXX | XXX | XXX |
| P/E/Growth | 2.0x | XXX | XXX | XXX |
| EV/FCF | 24.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpYunnan Baiyao Group's NTM/LTM revenue growth is 5%
Yunnan Baiyao Group's revenue per employee for the last fiscal year averaged $1.6M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Yunnan Baiyao Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Yunnan Baiyao Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Yunnan Baiyao Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 20% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.6M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | -4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 16% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Yunnan Baiyao Group acquired XXX companies to date.
Last acquisition by Yunnan Baiyao Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Yunnan Baiyao Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Yunnan Baiyao Group founded? | Yunnan Baiyao Group was founded in 1993. |
| Where is Yunnan Baiyao Group headquartered? | Yunnan Baiyao Group is headquartered in China. |
| How many employees does Yunnan Baiyao Group have? | As of today, Yunnan Baiyao Group has 3.5K+ employees. |
| Who is the CEO of Yunnan Baiyao Group? | Yunnan Baiyao Group's CEO is Mr. Ming Dong. |
| Is Yunnan Baiyao Group publicy listed? | Yes, Yunnan Baiyao Group is a public company listed on SHE. |
| What is the stock symbol of Yunnan Baiyao Group? | Yunnan Baiyao Group trades under 000538 ticker. |
| When did Yunnan Baiyao Group go public? | Yunnan Baiyao Group went public in 1993. |
| Who are competitors of Yunnan Baiyao Group? | Similar companies to Yunnan Baiyao Group include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Yunnan Baiyao Group? | Yunnan Baiyao Group's current market cap is $13.9B |
| What is the current revenue of Yunnan Baiyao Group? | Yunnan Baiyao Group's last 12-month revenue is $5.6B. |
| What is the current EBITDA of Yunnan Baiyao Group? | Yunnan Baiyao Group's last 12-month EBITDA is $767M. |
| What is the current EV/Revenue multiple of Yunnan Baiyao Group? | Current revenue multiple of Yunnan Baiyao Group is 2.2x. |
| What is the current EV/EBITDA multiple of Yunnan Baiyao Group? | Current EBITDA multiple of Yunnan Baiyao Group is 15.9x. |
| What is the current revenue growth of Yunnan Baiyao Group? | Yunnan Baiyao Group revenue growth between 2023 and 2024 was 2%. |
| Is Yunnan Baiyao Group profitable? | Yes, Yunnan Baiyao Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
